Article
Detecting EGFR Gene Mutations on a Nanobioarray Chip
2025-12-18
Abstract excerpt
In this study, three point mutations of EGFR relevant to lung cancer therapy are detected. Mutated EGFR is the target of a therapy for non-small cell lung cancer (NSCLC) using tyrosine kinase inhibitors (TKIs) as treatment drugs. Background/Objectives: Point mutations in exon 21 (L858R and L861Q) of the EGFR gene are TKI-sensitive; however, mutations in exon 20 (T790M) are TKI-resistant. Therefore, a fast detectio...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b7abca07-73d8-5314-9e30-530973b5b0d6
- DOI
- 10.20944/preprints202512.1447.v1
